MOD-GRF (1-29) + Hexarelin Blend 10mg
CAS: 863288-34-0 / 140703-51-1
MOD-GRF (1-29) + Hexarelin 10mg Blend by BioPeptides is a high-purity research-grade peptide combination formulated for advanced laboratory studies of growth hormone signaling, receptor pathway dynamics, and endocrine signaling interactions. Synthesized using precision solid-phase peptide synthesis and purified to ≥99% HPLC, this blend offers excellent molecular stability and reproducibility. Identified by CAS 863288-34-0 (MOD-GRF 1-29) and CAS 140703-51-1 (Hexarelin), it is widely used in controlled in-vitro research across Europe and the United States.
$215.00
Research Use Only
Research Overview
MOD-GRF (1-29) + Hexarelin is a dual-peptide blend studied extensively in growth-hormone axis research.
Researchers investigate the blend to analyze interactions between GHRH receptor signaling and ghrelin receptor activation.
The combination provides a useful model for studying synergistic endocrine signaling pathways.
The 10mg research format supports multiple experimental runs and controlled laboratory investigations.
Scientific Background
MOD-GRF (1-29) is a modified fragment of growth-hormone-releasing hormone engineered for enhanced stability and receptor interaction.
Hexarelin is a synthetic hexapeptide that activates the ghrelin receptor (GHS-R).
Researchers use the combination to study coordinated receptor activation within the growth-hormone signaling axis.
Because the peptides act through distinct receptor pathways, the blend is valuable for comparative endocrine signaling research.
Mechanistic Research Perspective
- GHRH receptor activation research
- Ghrelin receptor (GHS-R) signaling pathway analysis
- Dual-pathway growth-hormone axis activation models
- Receptor synergy and cross-talk investigation
- Peptide-mediated endocrine signaling pathway studies
Primary Research Applications
Growth Hormone Axis Research: The blend is used to investigate coordinated activation of growth-hormone signaling pathways in laboratory research models.
Receptor Cross-Talk Studies: Researchers study interactions between GHRH receptors and ghrelin receptors using this dual-peptide system.
Pulsatile Signaling Models: The peptide combination supports studies examining temporal dynamics of endocrine signaling.
Cellular & Molecular Biology Research: Laboratories incorporate the blend into cell-based assays to analyze downstream transcriptional and signaling responses.
Comparative Endocrine Pathway Research: The combination is widely used to compare single-receptor activation versus dual-pathway signaling effects.
Molecular Characteristics
- Compound Name: MOD-GRF (1-29) + Hexarelin Blend
- CAS Numbers: 863288-34-0 (MOD-GRF 1-29), 140703-51-1 (Hexarelin)
- Peptide Class: GHRH analog + GHS-R agonist peptide blend
- Form: Lyophilized peptide powder blend
- Purity: ≥99% HPLC verified
- Unit Size: 10mg research format
Stability Profile and Storage Recommendations
- Store lyophilized peptides at −20°C
- Protect from moisture and light exposure
- Avoid repeated freeze–thaw cycles
- Reconstitute using sterile laboratory-grade solvent
- Seal vial tightly after use
Solubility and Preparation Considerations
- Soluble in sterile bacteriostatic water
- Compatible with buffered aqueous laboratory solutions
- Suitable for peptide research protocols
- Applicable in receptor signaling assay preparations
- Compatible with cell culture experimental models
Technical Specifications
product Name
MOD-GRF (1-29) + Hexarelin Blend 10mg
brand
BioPeptides
cas
863288-34-0 / 140703-51-1
purity
≥99% (HPLC verified)
unit Size
10mg vial
form
Lyophilized peptide powder blend
synthesis
Solid-phase peptide synthesis (SPPS)
analytical
HPLC and mass spectrometry verification
molecular Structure
Dual peptide blend targeting GH-axis signaling
stability
Stable under −20°C storage conditions
Analytical Validation and Quality Assurance
- High-resolution HPLC purity testing
- Peptide identity verification
- Structural integrity analysis
- Batch-to-batch consistency validation
- Peptide stability testing
Regulatory and Compliance Statement
MOD-GRF (1-29) + Hexarelin supplied by BioPeptides is intended strictly for laboratory research use only. It is not approved for human consumption, veterinary use, therapeutic applications, or medical treatments.
Frequently Asked Questions
The blend is primarily studied for growth-hormone axis signaling, receptor synergy, and endocrine pathway interactions in controlled laboratory models.
MOD-GRF (1-29) activates the GHRH receptor while Hexarelin targets the ghrelin receptor, allowing researchers to study dual-pathway signaling and receptor cross-talk.
CAS 863288-34-0 and 140703-51-1 uniquely identify each peptide, ensuring accurate documentation and reproducibility across research laboratories.
Yes. The blend is commonly used in receptor assays, signaling pathway experiments, and endocrine research models.
It is widely used in endocrinology research, molecular biology, receptor pharmacology, and peptide signaling studies.
The 10mg format allows multiple experimental runs while minimizing peptide waste and improving laboratory efficiency.
The peptides should be stored at −20°C in lyophilized form and protected from moisture and light.
BioPeptides provides high-purity peptides with verified CAS documentation and reliable international supply for research laboratories.